SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-21-002220
Filing Date
2021-02-22
Accepted
2021-02-22 16:43:42
Documents
2
Period of Report
2021-02-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-51511.html 3  
1 PRIMARY DOCUMENT marketforms-51511.xml 3 1718
2 POA DOCUMENT poa.htm EX-24 2977
  Complete submission text file 0001214659-21-002220.txt   6141
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK NY 10022
Business Address
Taglietti Marco (Reporting) CIK: 0001408870 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38599 | Film No.: 21660964